Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Bresnik, MD
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
71 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- University of California - San Diego
La Jolla, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Kaiser Permanente Medical Center
Oakland, California, United States
- National Jewish Health
Denver, Colorado, United States
- Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Central Florida Pulmonary Group
Altamonte Springs, Florida, United States
- University of Florida
Gainesville, Florida, United States
- South Broward Hospital Dba Memorial Healthcare System
Hollywood, Florida, United States
- Nemours Children'S Clinic - Jacksonville
Jacksonville, Florida, United States
- University of Miami
Miami, Florida, United States
- Arnold Palmer Hospital for Children
Orlando, Florida, United States
- Nemours Children'S Clinic - Orlando
Orlando, Florida, United States
- Nemour'S Children'S Clinic
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Emory Cystic Fibrosis Center
Atlanta, Georgia, United States
- Georgia Health
Augusta, Georgia, United States
- St. Lukes Medical Center
Boise, Idaho, United States
- University of Chicago
Chicago, Illinois, United States
- Chicago Cf Care Specialists Nfp Dba Cystic Fibrosis Institure
Glenview, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Maine Medical Center
Portland, Maine, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Harper University Hospital
Detroit, Michigan, United States
- Spectrum Health - Helen Devos Children'S Hospital
Grand Rapids, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- St. Louis University - Cardinal Glennon Children'S Hospital
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Children'S Lung Specialists
Las Vegas, Nevada, United States
- Dartmouth Hitchcock Specialty Care Clinic
Bedford, New Hampshire, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Morristown Medical Center
Morristown, New Jersey, United States
- Unm Clinical and Translational Center
Albuquerque, New Mexico, United States
- Albany Medical College
Albany, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2012
- Primary completion
- 31 Jan 2015
- Completion
- 31 Jan 2015
- Last update posted
- 9 May 2016
- Registered enrollment
- 107
- Registry id
- NCT01641822
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.